hsa-mir-541-5p _LIHC.png
hsa-mir-4529-3p _LIHC.png
hsa-mir-548ar-3p _LIHC.png
FRK _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020175
Fusion event
HBV-FRK integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1163
End
2259
Orient
+
Integrated sequence
GTCAGGTCTCTGCCAAGTGTTTGCTGACGCAACCCCCACGGGTTGGGGCTTGGCCATAGGCCATCGGCGCATGCGTGGAACCTTTGTGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTC
Host Sequence
Chromosome
chr6
Cytoband
q22.1
Reference genome
End
116272515/115951352 (Hg38)
Orient
+
Location type
Intronic
Target gene
miRNAs that regulate target gene
hsa-mir-335-5p ; hsa-mir-6867-5p ; hsa-mir-5682 ; hsa-mir-9-3p ; hsa-mir-6832-5p ; hsa-mir-4732-5p ; hsa-mir-6499-3p ; hsa-mir-5584-5p ; hsa-mir-4519 ; hsa-mir-29c-3p ; hsa-mir-29b-3p ; hsa-mir-29a-3p ; hsa-mir-6873-5p ; hsa-mir-4302 ; hsa-mir-6871-3p ; hsa-mir-4422 ; hsa-mir-6835-3p ; hsa-mir-129-5p ; hsa-mir-3680-3p ; hsa-mir-557 ; hsa-mir-507 ; hsa-mir-450b-5p ; hsa-mir-6788-5p ; hsa-mir-30c-2-3p ; hsa-mir-30c-1-3p ; hsa-mir-8085 ; hsa-mir-6731-5p ; hsa-mir-4714-3p ; hsa-mir-6878-5p ; hsa-mir-6871-5p ; hsa-mir-4282 ; hsa-mir-1261 ; hsa-mir-151a-3p ; hsa-mir-891a-3p ; hsa-mir-3688-5p ; hsa-mir-4463 ; hsa-mir-4499 ; hsa-mir-1243 ; hsa-mir-186-5p ; hsa-mir-3133 ; hsa-mir-6892-5p ; hsa-mir-203a-3p ; hsa-mir-6730-5p ; hsa-mir-7843-5p ; hsa-mir-6879-5p ; hsa-mir-6735-5p ; hsa-mir-4632-5p ; hsa-mir-4436b-3p ; hsa-mir-3974 ; hsa-mir-3646 ; hsa-mir-8077 ; hsa-mir-7160-5p ; hsa-mir-4663 ; hsa-mir-6761-5p ; hsa-mir-7853-5p ; hsa-mir-105-5p ; hsa-mir-4728-3p ; hsa-mir-607 ; hsa-mir-4435 ; hsa-mir-488-3p ; hsa-mir-3671 ; hsa-mir-503-3p ; hsa-mir-31-5p ; hsa-mir-3922-3p ; hsa-mir-3176 ; hsa-mir-3190-5p ; hsa-mir-6837-5p ; hsa-mir-4685-5p ; hsa-mir-4692 ; hsa-mir-4514 ; hsa-mir-6715b-5p ; hsa-mir-4269 ; hsa-mir-4742-5p ; hsa-mir-4698 ; hsa-mir-8063 ; hsa-mir-3187-3p ; hsa-mir-4529-5p ; hsa-mir-5191 ; hsa-mir-6847-3p ; hsa-mir-490-5p ; hsa-mir-195-3p ; hsa-mir-16-2-3p ; hsa-mir-6876-5p ; hsa-mir-4476 ; hsa-mir-4662a-5p ; hsa-mir-103b ; hsa-mir-3688-3p ; hsa-mir-8076 ; hsa-mir-450a-1-3p ; hsa-mir-2110 ; hsa-mir-6883-3p ; hsa-mir-3147 ; hsa-mir-4425 ; hsa-mir-4694-5p ; hsa-mir-6780b-5p ; hsa-mir-4725-3p ; hsa-mir-4271 ; hsa-mir-6739-5p ; hsa-mir-6733-5p ; hsa-mir-3153 ; hsa-mir-4668-5p ; hsa-mir-711 ; hsa-mir-4738-3p ; hsa-mir-454-5p ; hsa-mir-3938 ; hsa-mir-3654 ; hsa-mir-4661-5p ; hsa-mir-541-5p ; hsa-mir-522-3p ; hsa-mir-224-3p ; hsa-mir-4694-3p ; hsa-mir-548f-3p ; hsa-mir-548e-3p ; hsa-mir-548az-3p ; hsa-mir-548ar-3p ; hsa-mir-548a-3p ; hsa-mir-1248 ; hsa-mir-1237-3p ; hsa-mir-4529-3p ; hsa-mir-7850-5p ; hsa-mir-4520-2-3p ; hsa-mir-384 ; hsa-mir-7975 ; hsa-mir-4520-3p ; hsa-mir-5571-3p ; hsa-mir-6877-3p ; hsa-mir-6819-3p
Nearest miRNA
hsa-mir-10398/Upstream/9166084; hsa-mir-1202/Downstream/3117695;
Nearest cancer related gene
FRK(TSG, No orient, 0)
Upstream sequence
gtaaaataaaaccataatgagataatactgcacatctgccacaatggataacatcttcaaaagattaacaattttaattggaaaaaaatattgggaagta
Downstream sequence
tatatgaagtaagtattgcaattattcttccccatttcatagGAATTCCTTTTACTCAAAGGAATAGGTAACAAGTTGTGTGACCTATAATAGATGTTCT
Target sequence
gaatctacagggaacttaaacaaatttacaagaaataaaaaccatcaaaaagtgggcaaaggatatgaacagacacttttcaaaagaagacattcatgcagtcaacaaatatatgaaaaaaagctcatcatcactagagaaatccaaaccaaaaccacaatgagatagcatgtcatgtcagttagaatgggatcattaaaaagtcaggaaacaacagatgctggagaggatgtggagaaagaggaatgcttttac
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Curate